+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Primary endometrioid stromal sarcoma of the ovary: a clinicopathologic study of 27 cases with morphologic and behavioral features similar to those of uterine low-grade endometrial stromal sarcoma



Primary endometrioid stromal sarcoma of the ovary: a clinicopathologic study of 27 cases with morphologic and behavioral features similar to those of uterine low-grade endometrial stromal sarcoma



American Journal of Surgical Pathology 38(3): 305-315



Twenty-seven endometrioid stromal sarcomas of the ovary from patients 38 to 76 (mean 56) years of age are reported. The tumors were unilateral in 20 cases and bilateral in 7. They were solid (9), solid and cystic (9), or predominantly cystic (6) when this information was known and ranged from 1 to 20 (mean 9.5) cm. The solid areas typically had a tan-yellow cut surface, with areas of hemorrhage and/or necrosis noted in 6; however, in addition, blood was often present in the cyst lumens. On microscopic examination, the predominant and frequently exclusive pattern was a diffuse growth of small cells with interspersed arterioles, the latter appearing round to elongated. A fibromatous pattern was present in 14 of the tumors but was extensive in only 3. A vague nodular growth was observed in 10 tumors but was never striking; a storiform growth was seen in 2 tumors, being conspicuous in 1. Hyaline plaques were present in 10 tumors but were striking in only 2. Sex cord-like or smooth muscle differentiation was seen in 7 and 6 tumors, respectively, being striking in 2 and 3 of them. Foam cells were present in 6 tumors. The tumors showed minimal cytologic atypia. The mitotic index ranged from <1 to 17/10 high-power fields (HPF), being <1/10 HPF in 12, 1 to 5/10 HPF in 9, 6 to 10/10 HPF in 2, and >10/10 HPF in 4 tumors. Infarct-type necrosis was noted in 12 tumors. Hemorrhage, typically recent, was seen in 20 cases, being conspicuous in 5. Ovarian endometriosis was intimately associated with the tumor in 16 cases. Seven patients had stage I tumors, 5 stage II, 13 stage III, and 2 stage IV. Follow-up information was available for 21 patients; 10 were alive and free of disease from 4 to 21 years postoperatively (follow-up being ≥ 11 y in 5); 6 were alive with disease from 1 to 22 years postoperatively; 5 patients are known to have died of disease, with the interval being unknown in 1, and 2, 4, 13, and 17 years in the others. Follow-up information was unavailable in the remaining 6 patients. These findings indicate that these tumors, as in the uterus, often have an indolent course with a better prognosis than other ovarian sarcomas, indicating the importance of correct diagnosis. The differential diagnosis of these neoplasms is in the first instance with a metastasis from the uterus; knowledge of the status of the uterus is paramount in this distinction. Associated ovarian endometriosis suggests a primary tumor. When a primary ovarian origin is determined, the differential diagnosis is most often with a sex cord-stromal tumor, particularly a granulosa cell tumor because of a diffuse growth of cells with scant cytoplasm.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 055177138

Download citation: RISBibTeXText

PMID: 24525500

DOI: 10.1097/pas.0000000000000145


Related references

Prognostic value of the diagnostic criteria distinguishing endometrial stromal sarcoma, low grade from undifferentiated endometrial sarcoma, 2 entities within the invasive endometrial stromal neoplasia family. International Journal of Gynecological Pathology 32(3): 299-306, 2013

Test and teach. A uterine tumour causing a diagnostic dilemma. Low-grade endometrial stromal sarcoma with extensive endometrioid glandular differentiation. Pathology 35(4): 344-346, 2003

Low grade endometrial stromal sarcoma of uterine: review of 17 cases. Acta Medica Iranica 49(9): 619-624, 2012

Clinicopathologic features and prognostic factors of endometrial stromal sarcoma: a study of 55 cases. Zhonghua Bing Li Xue Za Zhi 40(8): 517-522, 2012

The classification of a uterine sarcoma as 'high-grade endometrial stromal sarcoma' should be abandoned. Gynecologic Oncology 95(2): 412-3; Author Reply 413, 2004

Localized high grade endometrial stromal sarcoma and localized undifferentiated uterine sarcoma: a retrospective series of the French Sarcoma Group. International Journal of Gynecological Cancer 2019, 2019

Ovary and uterus-sparing procedures for low-grade endometrial stromal sarcoma: a retrospective study of 153 cases. Gynecologic Oncology 132(3): 654-660, 2014

Lymphadenectomy in uterine low-grade endometrial stromal sarcoma: an analysis of 19 cases and a literature review. International Journal of Gynecological Cancer 20(8): 1363-1366, 2011

Endometrioid stromal sarcoma: a clinicopathologic study of 63 cases. American Journal of Surgical Pathology 37(11): 1635-1647, 2013

A well circumscribed uterine endometrial stromal tumor with smooth muscle differentiation recurred as a low grade endometrial stromal sarcoma: is tumor margin enough for the diagnosis?. Pathology International 62(5): 363-365, 2012

Low grade endometrial stromal sarcoma of uterine corpus, a clinico-pathological and survey study in 14 cases. World Journal of Surgical Oncology 4: 50, 2006

Extrauterine low-grade endometrial stromal sarcoma with florid endometrioid glandular differentiation. International Journal of Gynecological Pathology 20(4): 395-398, 2001

Metastatic pulmonary nodules of uterine low-grade endometrial stromal sarcoma histopathological and immunohistochemical analysis of 10 cases. 2013

Pulmonary metastatic nodules of uterine low-grade endometrial stromal sarcoma: histopathological and immunohistochemical analysis of 10 cases. Histopathology 63(6): 833-840, 2014

Phase 2 trial of mifepristone (RU-486) in advanced or recurrent endometrioid adenocarcinoma or low-grade endometrial stromal sarcoma. Cancer 115(9): 1867-1874, 2009